Filing Details
- Accession Number:
- 0001567619-21-006685
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-19 16:06:46
- Reporting Period:
- 2021-03-17
- Accepted Time:
- 2021-03-19 16:06:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1601485 | Angion Biomedica Corp. | ANGN | Pharmaceutical Preparations (2834) | 113430072 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640447 | F. John Neylan | C/O Angion Biomedica Corp. 51 Charles Lindbergh Blvd. Uniondale NY 11553 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-17 | 442 | $19.13 | 38,453 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold to the Issuer solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a Restricted Stock Awards ("RSAs") of the Issuer.
Billionaire Hedge Funds
